A federal judge in Maryland expressed concerns on Monday over a drug company’s ongoing lack of “good faith substantial compliance” with an injunction. This follows a $15 million jury verdict concerning a dispute over a proprietary probiotic formula. The legal battle illustrates ongoing challenges in ensuring adherence to judicial mandates, particularly in complex intellectual property disputes. Legal professionals may find it beneficial to follow the proceedings of this case as it unfolds, which could potentially offer further insights into judicial enforcement in corporate litigation. Additional details on this case are available through Law360.